These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Humoral and cell mediated immune responses to porins of Salmonella typhi. Sharma P; Ganguly NK; Sharma BK; Sharma S; Rawal IJ; Saxena SN; Sehgal R Jpn J Exp Med; 1989 Apr; 59(2):73-7. PubMed ID: 2545961 [TBL] [Abstract][Full Text] [Related]
3. Induction of cellular immune response and anti-Salmonella enterica serovar typhi bactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever. Salazar-González RM; Maldonado-Bernal C; Ramírez-Cruz NE; Rios-Sarabia N; Beltrán-Nava J; Castañón-González J; Castillo-Torres N; Palma-Aguirre JA; Carrera-Camargo M; López-Macías C; Isibasi A Immunol Lett; 2004 May; 93(2-3):115-22. PubMed ID: 15158606 [TBL] [Abstract][Full Text] [Related]
4. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933 [TBL] [Abstract][Full Text] [Related]
5. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948 [TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies against the lipopolysaccharide of Salmonella typhi 9,12,VI:d. Analysis of passive protection in a mouse model of typhoid fever]. Paniagua J; Isibasi A; Pelayo R; Ortiz V; Muy M; González C; García JA; Islas S Arch Invest Med (Mex); 1989; 20(4):315-20. PubMed ID: 2488771 [TBL] [Abstract][Full Text] [Related]
7. Evolution of the typhoid immunity along one year after intradermal vaccination. Dimache G; Croitoru M; Ciordaş C; Velea V Arch Roum Pathol Exp Microbiol; 1986; 45(2):147-52. PubMed ID: 3800632 [No Abstract] [Full Text] [Related]
8. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a. Chau PY; Tsang RS Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471 [TBL] [Abstract][Full Text] [Related]
9. Salmonella typhi--induced stimulation of blood lymphocytes from persons with previous typhoid fever. Mogensen HH Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):41-5. PubMed ID: 433604 [TBL] [Abstract][Full Text] [Related]
10. [Elaboration of an immunosorbent for the purification of porins from Salmonella typhi 9, 12, Vi:d]. Pelayo R; Isibasi A; Paniagua J; Ortíz V; Muy M; González C; Blanco F; Islas S; Kumate J Arch Invest Med (Mex); 1989; 20(4):279-86. PubMed ID: 2562234 [TBL] [Abstract][Full Text] [Related]
11. Specific immune responses in typhoid fever & after TAB vaccination. Bhaskaram P; Sahay BK; Rao NS Indian J Med Res; 1990 Mar; 91():115-9. PubMed ID: 2345018 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience with typhoid vaccine in Thailand. Sarasombath S Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):471-4. PubMed ID: 3064324 [TBL] [Abstract][Full Text] [Related]
13. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever. Das S; Chowdhury R; Pal A; Okamoto K; Das S Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553 [TBL] [Abstract][Full Text] [Related]
14. Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties. Moreno-Eutimio MA; Tenorio-Calvo A; Pastelin-Palacios R; Perez-Shibayama C; Gil-Cruz C; López-Santiago R; Baeza I; Fernández-Mora M; Bonifaz L; Isibasi A; Calva E; López-Macías C Immunology; 2013 Aug; 139(4):459-71. PubMed ID: 23432484 [TBL] [Abstract][Full Text] [Related]
15. Cellular immunity against Salmonella typhi after live oral vaccine. Nencioni L; Villa L; De Magistris MT; Romano M; Boraschi D; Tagliabue A Adv Exp Med Biol; 1987; 216B():1669-75. PubMed ID: 3501237 [No Abstract] [Full Text] [Related]
17. Immune response variations to Salmonella enterica serovar Typhi recombinant porin proteins in mice. Toobak H; Rasooli I; Talei D; Jahangiri A; Owlia P; Darvish Alipour Astaneh S Biologicals; 2013 Jul; 41(4):224-30. PubMed ID: 23796754 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice. Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of oral and subcutaneous immunization against typhoid-paratyphoid fever (author's transl)]. Krasnoproshina LI Acta Microbiol Acad Sci Hung; 1974; 21(1-2):151-60. PubMed ID: 4216249 [No Abstract] [Full Text] [Related]
20. Vaccination against typhoid fever with a live oral vaccine. Germanier R Dev Biol Stand; 1976; 33():85-8. PubMed ID: 782975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]